In vitro activity of voriconazole and three other antifungal agents against dermatophytes;Actividad in vitro de voriconazol y otros tres antifúngicos frente a dermatofitos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 9, 2003, Pages 484-487

  Serrano Martino, María Del Carmen ^a   Chávez Caballero, Mónica ^a   Valverde Conde, Anastasio ^a   Claro, Rosa María ^a   Pemán, Javier ^b   Martín Mazuelos, Estrella ^a,c  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c Hospital Universitario de Cadiz   (Spain)

Author keywords

Dermatophytes; Microdilution; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATOMYCOSIS; DERMATOPHYTE; DILUTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SENSITIVITY; IN VITRO STUDY; MICROSPORUM CANIS; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; NAPHTHALENES; PYRIMIDINES; SPECIES SPECIFICITY; TRIAZOLES; TRICHOPHYTON;

EID: 0344872554     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052331     Document Type: Article

References (23)

1. Larone DH. Culture and identification of dermatophytes. Clin Microbiol Newsl 1996;18:33-8.
2. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995;8:240-59.
3. Macura A. Dermatophytes, pathogens or saprophytes. Int J Dermatol 1995;34:529-30.
4. Cabañes J. Identificación de hongos dermatófitos. En: Pemán J, Martín-Mazuelos E, Rubio C, editores. Guía práctica de identificación y diagnóstico en micología clínica. Bilbao: Rev Iberoam Micología 2001;12:1-11.
5. Berger AR. Common superficial fungal infections in patient with AIDS. Clin Infect Dis 1996;22:128-32.
6. Ray MC, Gately LE. Dermatology manifestation of HIV infection in AIDS. Infect Dis Clin North Am 1994;94:583-605.
7. Roberts DT. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology 1997;194:37-9.
8. Saul A, Bonifaz A, Arias I. Itraconazole in the tratment of superficial mycoses: An open trial of 40 cases. Rev Infect Dis 1987;9:S100-S3.
9. Chávez M, Bernal S, Valverde A, Gutiérrez MJ, Quindós G, Martín Mazuelos E. In vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp isolates from HIV infected patients. J Antimicrob Chemother 1999;44:697-700.
10. Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis 2000;38:101-7.
11. Marco F, Pfaller MA, Messer S, Jones RN. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrob Agents Chemother 1998;42:161-3.
12. Pfaller MA, Messer SA, Hollis RJ, Jones R, the Sensitry Participants Group Antifungal activities of posaconazole, ravuconazole and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi program 2000. Antimicrob Agents Chemother 2002;46:1032-7.
13. Cuenca Estrella M, Rodríguez Tudela JL, Mellado E, Martínez-Suárez JV, Monzón A. Comparison of the in vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. J Antimicrob Chemother 1998;42:531-3.
14. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi 1998 National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Fernández-Torres B, Carrillo AJ, Martín E, Del Palcio A, Moore MK, Valverde A, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001;45:2524-8.
16. Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro M, Guarro J. In vitro susceptibility of itraconazole, clotrimazole, ketoconazole and terbinafina of 100 isolates of Trichophyton rubrum. Chemotherapy 2000;46:390-4.
17. Norris HA, Elewski BE, Ghannoum MA. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dematophytes with the use of a microdilution method. J Am Acad Dermatol 1999;40(6, part 2):S9-S13.
18. Artis WM, Odle BM, Jones HE. Griseofulvin-resistant dermatophytosis correlates with in vivo resistance. Arch Dermatol 1981;117:16-9.
19. Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001;39:385-8.
20. Wildfeuer A, Seidl HP, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeaste, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998;41:309-19.
21. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes. Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000;38:341-4.
22. Espinel-Ingroff A. In vitro activity of the new triazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998;36:198-202.
23. Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibility of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol 1999;37:858-61.